Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 12, pp. 905-914
Open Access | Times Cited: 23

Showing 23 citing articles:

Applications of SGLT2 inhibitors beyond glycaemic control
Daniel V. O’Hara, Carolyn S.P. Lam, John J.V. McMurray, et al.
Nature Reviews Nephrology (2024) Vol. 20, Iss. 8, pp. 513-529
Closed Access | Times Cited: 26
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction
Caio A.M. Tavares, Luciano César Pontes Azevedo, Álvaro Réa-Neto, et al.
JAMA (2024) Vol. 332, Iss. 5, pp. 401-401
Closed Access | Times Cited: 16
The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: evidence from a network meta-analysis
Ping‐Tao Tseng, Bing‐Yan Zeng, Chih-Wei Hsu, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Myocardial Oedema as a Consequence of Viral Infection and Persistence—A Narrative Review with Focus on COVID-19 and Post COVID Sequelae
N Panagiotides, Michael Poledniczek, Martin Andreas, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 121-121
Open Access | Times Cited: 6
Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials
Claire L. Vale, Peter J. Godolphin, David J. Fisher, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 10, pp. 735-747
Open Access | Times Cited: 5
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR‐Preserved analysis
João Pedro Ferreira, Faı̈ez Zannad, Milton Packer, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 4, pp. 952-959
Closed Access | Times Cited: 4
Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
Mikhail Kosiborod, Sheryl L. Windsor, Orly Vardeny, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 10, pp. 725-734
Open Access | Times Cited: 4
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Amr E. Abbas, Fatima Abbas, et al.
EClinicalMedicine (2025) Vol. 81, pp. 103080-103080
Closed Access
COVID-19 and Diabetes: Persistent Cardiovascular and Renal Risks in the Post-Pandemic Landscape
Tzu-Shan Huang, Jo-Yen Chao, Ho-Hsiang Chang, et al.
Life (2025) Vol. 15, Iss. 5, pp. 726-726
Open Access
An Updated Prioritization of Geroscience- Guided FDA-Approved Drugs Repurposed to Target Aging
Michael Leone, Nir Barzilai
Medical Research Archives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 3
Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby, Natalie Staplin, Leon Peto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Immunity and Coagulation in COVID-19
П. П. Авдонин, Maria S. Blinova, Anastasia A. Serkova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11267-11267
Open Access | Times Cited: 3
Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19
Carmen Tisch, Eleni Xourgia, Aristomenis K. Exadaktylos, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 660-675
Open Access | Times Cited: 2
Heart failure and respiratory tract infection: Cause and consequence of acute decompensation?
Bettina Heidecker, Matteo Pagnesi, Thomas F. Lüscher
European Journal of Heart Failure (2024) Vol. 26, Iss. 4, pp. 960-962
Closed Access | Times Cited: 2
A Systematic Review and Meta-analysis on the Safety and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitor Use in Hospitalized Patients
Frank Gao, Aleena S. Ali, Rinaldo Bellomo, et al.
Diabetes Care (2024) Vol. 47, Iss. 12, pp. 2275-2290
Closed Access | Times Cited: 2
Targeting the endothelium by combining endothelin-1 antagonism and SGLT-2 inhibition: better together?
Philip Ambery, Peter J. Greasley, Robert Menzies, et al.
Clinical Science (2024) Vol. 138, Iss. 11, pp. 687-697
Open Access | Times Cited: 1
Visceral fat as the main tomographic risk factor for COVID-19 mortality
Luis Ricardo Hinojosa-Gutiérrez, Antonio González, Jair Antonio Rios-Muñoz, et al.
Heart & Lung (2024) Vol. 70, pp. 191-196
Closed Access | Times Cited: 1
Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?
Medine Cumhur Cüre, Erkan Cüre
Current Pharmaceutical Design (2024) Vol. 30, Iss. 15, pp. 1149-1156
Closed Access
SGLT2 Inhibitors in COVID-19: Umbrella Review, Meta-analysis, and Bayesian Sensitivity Assessment
Vinay Suresh, Muhammad Aaqib Shamim, Victor Ghosh, et al.
Research Square (Research Square) (2024)
Open Access
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby, Jonathan Emberson, Louise Thwaites, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure
Muhammad Sameer Arshad, Adeena Jamil, Stephen J. Greene, et al.
Heart Failure Reviews (2024)
Closed Access
In-hospital management of non-surgical patients treated with gliflozins
Michal Šitina
Vnitřní lékařství (2024) Vol. 70, Iss. 7, pp. E3-E7
Open Access
A systematic review and meta-analysis assessing the safety and efficacy of sodium-glucose co-transporter 2 inhibitor use in hospitalized patients
Feng Gao, Aleena S. Ali, Rinaldo Bellomo, et al.
(2024)
Open Access
Page 1

Scroll to top